Market cap falls to £26m
Following underperformance
Recognising the best new talent
Nominate now for new Rising Star Award
First fund to be risk profiled by Dynamic Planner
J.P. Morgan Cazenove turns 'neutral' on investment trust
Outlooks for the biotech sector
'Unique record' to be maintained
'Reliable source of income'